NAT and blood safety: what is the paradigm?

Editorial

M P Busch et al. Transfusion. 2000 Oct.

. 2000 Oct;40(10):1157-60.

doi: 10.1046/j.1537-2995.2000.40101157.x.

No abstract available

Comment in

NAT and blood safety.
Sherman LA. Sherman LA. Transfusion. 2001 Feb;41(2):304-5. doi: 10.1046/j.1537-2995.2001.4102304.x. Transfusion. 2001. PMID: 11239241 No abstract available.

NAT of the United States and Canadian blood supply.
Stramer SL, Caglioti S, Strong DM. Stramer SL, et al. Transfusion. 2000 Oct;40(10):1165-8. doi: 10.1046/j.1537-2995.2000.40101165.x. Transfusion. 2000. PMID: 11061850 Review. No abstract available.
Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.
Legler TJ, Riggert J, Simson G, Wolf C, Humpe A, Munzel U, Uy A, Köhler M, Heermann KH. Legler TJ, et al. Transfusion. 2000 Oct;40(10):1192-7. doi: 10.1046/j.1537-2995.2000.40101192.x. Transfusion. 2000. PMID: 11061854
Residues of NAT: questions and commentary.
Sherman LA. Sherman LA. Transfusion. 2000 Oct;40(10):1268-72. doi: 10.1046/j.1537-2995.2000.40101268.x. Transfusion. 2000. PMID: 11061867 No abstract available.